RESOURCES

Service partnership agreement between Oncodesign and Galderma

Press Release: Multi-year service contract: design and discover new drug candidates in dermatology - Galderma.

Unraveling the Interaction between Carboxylesterase 1c and the Antibody-Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout Mice

Unraveling the Interaction between Carboxylesterase 1c and the Antibody-Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout Mice

Centre Georges François Leclerc Presents the Detailed Results of the First Two Stages of its Clinical Study in Lung Cancer at the EANM Congress

Presentation of detailed results from the first two stages of the clinical trial in lung cancer | 31st EANM1 | 2018.

Precision medicine: Cap Digital and Medicen Paris-Region team-up with Oncodesign, Servier and Intersystems on Hu-PreciMED

Hu-PreciMED project will gear French precision medicine industry towards discovering new diagnostic approaches & novel therapeutic treatments.

Oncodesign furthers its cooperation with Eisai, started 12 years ago

This services agreement aims to evaluate the anti-tumor efficacy of Eisai new compounds...

[EN] Drug biodistribution & efficacy: how can radiolabeling a molecule make the difference?

[FR] Le Monde – Maladies infectieuses : une plateforme d’imagerie de pointe

Oncodesign announces the results of the second stage of its clinical study in lung cancer

The results confirm the radiotracer’s potential as a companion biomarker for patientssuffering from non-small-cell lung cancer.

Idmit: inauguration of a new Biology and Health research infrastructure devoted to human infectious diseases and immunology

17th Annual World Preclinical Congress – Presentation

17th Annual World Preclinical Congress – SMPT: a tool for translational research

17th Annual World Preclinical Congress – Humanized mouse models for evaluation of cancer therapies